New coaching program aims to ease burden on lung cancer caregivers
NCT ID NCT05640765
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new care model called BeWell360-CG, which provides health and wellness coaching to caregivers of people with advanced lung cancer. The goal was to see if the program could reduce caregiver burden and improve their quality of life. Fifty-five caregivers participated, receiving coaching sessions and educational materials over several months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- health and wellness coaching program
- What this could lead to
- If successful, this program could provide a practical way to reduce stress and improve well-being for caregivers of advanced lung cancer patients.
- What could go wrong
- This was a small, early-stage study with only 55 participants, so results may not apply to all caregivers. The program requires time and commitment, which may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
55 people
The number who actually took part.
- Started
-
Feb 2021
- Finished
-
Apr 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * CGs of patients with advanced lung cancer receiving care at Mayo Clinic Florida (MCF) in the Palliative Care (PC) or Oncology clinics * Patient with a predicted life expectancy \>=6 months * Adult CGs' of any gender, race and ethnicity * English speaking * Willing to provide informed consent and complete HWC sessions, study interviews, and surveys. We will identify the respective patients through the patient appointment schedule list and use the patient electronic medical record (EMR) to confirm the point of contact of CGs. * Palliative Care staff participating in the research study Exclusion Criteria: * Patients or CGs who are unable to complete surveys, coaching sessions and participate in interviews. Palliative Care clinicians will determine inability to participate based on burden to patient and clinical diagnosis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced lung carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict and treat cancer wasting better? a new study investigates
- Facing the fear: a new program aims to ease anxiety in advanced cancer
- Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
- Could a simple assessment help older lung cancer patients tolerate chemo better?
- Could a muscle relaxant help fight lung cancer? scientists test papaverine with standard therapy
- Wheat germ supplement studied for immune boost in advanced cancer